US Congress House Bill 3777 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on October 8 2009 - 25% progression, died in committee
Action: 2009-10-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Drug Price Competition Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant to submit a substantially complete application that contains and lawfully maintains a certification for such drug.

Drug Price Competition Act of 2009

Rep. Alcee Hastings [D-FL]

Rep. Louise Slaughter [D-NY]

Rep. Gene Taylor [D-MS]

Date	Chamber	Action
2009-10-09		Referred to the Subcommittee on Health.
2009-10-08		Referred to the House Committee on Energy and Commerce.
2009-10-08		Sponsor introductory remarks on measure. (CR E2487-2488)

SB1315 (Same As) 2009-06-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Type	Source
Summary	https://www.congress.gov/bill/111th-congress/house-bill/3777/all-info
Text	https://www.congress.gov/111/bills/hr3777/BILLS-111hr3777ih.pdf